BIOLASE holds several other patents in the area of ophthalmology, and this most recent patent expands the application of the laser technology to include treatment of presbyopia, glaucoma, retinal disorders and cataracts.
Related Articles on Ophthalmology:
Vision Treatment Company AcuFocus Raises $65M in Funding
McCracken Eye and Face Institute Opens New Office in Boulder, Colorado
Cataract Surgery Gains Popularity as Surgical Option for Glaucoma
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.